Clin Exp Otorhinolaryngol.  2015 Sep;8(3):183-188. 10.3342/ceo.2015.8.3.183.

Evaluation of Hearing and Outer Hair Cell Function of Cochlea in Patients With Psoriatic Arthritis

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Dicle University Faculty of Medicine, Diyarbakir, Turkey. drmehmetakdag@hotmail.com
  • 2Department of Dermatology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
  • 3Department of Physical Therapy and Rehabilitation, Dicle University Faculty of Medicine, Diyarbakir, Turkey.

Abstract


OBJECTIVES
The aim of this study was to investigate hearing and outer cells function in patients with psoriatic arthritis. Our investigation was a prospective case control study.
METHODS
A total of 31 psoriatic arthritis patients (62 ears) and 31 healthy control subjects (62 ears) were enrolled in the study. We investigated hearing changes of patients and controls via pure tone audiometry, speech discrimination scores, tympanometry, acoustic reflex, and transient product otoacoustic emission.
RESULTS
The mean age of psoriatic arthritis patients was 36.1+/-8.5 years (range, 14 to 62 years). The average age of the control group was 37.9+/-8.1 years (range, 16 to 62 years). There were statistically significant differences between pure tone audiometry in all frequencies and right and left emission at the 4.0 and 1.0 in psoriatic arthritis patients versus controls (P<0.05). This difference was evident, especially at high frequencies. There was no statistically significant difference between the ages and genders of the patient and control groups (P>0.05). Both audiological and otoacoustic emissions were not significantly different between right and left ear (P>0.05).
CONCLUSION
Based on the audiological and otoacoustic findings; it is likely that the cochlear outer hair cells become subtly damaged in psoriatic arthritis patients, consequently leading to changes in hearing thresholds. These data suggest that it is important to screen psoriatic arthritis patients for hearing changes with otoacoustic emissions and audiologic tests regularly.

Keyword

Arthritis, Psoriatic; Hearing; Audiometry, Pure Tone; Otoacoustic Emissions, Spontaneous; Acoustic Impedance Tests

MeSH Terms

Acoustic Impedance Tests
Arthritis, Psoriatic*
Audiometry
Audiometry, Pure-Tone
Audiometry, Speech
Case-Control Studies
Cochlea*
Discrimination (Psychology)
Ear
Hair*
Hearing*
Humans
Otoacoustic Emissions, Spontaneous
Prospective Studies
Reflex, Acoustic

Figure

  • Fig. 1 Right audiometric graphic of frequency and pure tone thresholds of patient and control groups. Frequency of right audiometry: 250 Hz, P<0.001; 500 Hz, P<0.001; 1,000 Hz, P=0.011; 2,000 Hz, P<0.001; 4,000 Hz, P=0.001; 6,000 Hz, P<0.001.

  • Fig. 2 Left audiometric graphic of frequency and pure tone thresholds of patient and control groups. Frequency of left audiometry: 250 Hz, P=0.013; 500 Hz, P=0.023; 1,000 Hz, P=0.007; 2,000 Hz, P=0.002; 4,000 Hz, P=0.002; 6,000 Hz, P<0.001.

  • Fig. 3 Right otoacoustic emission graphic of frequency and sound noise ratio changes of patient and control groups. Frequency of right otoacoustic emission: 1.0 Hz, P=0.053; 1.4 Hz, P=0.683; 2.0 Hz, P=0.989; 2.8 Hz, P=0.714; 4.0 Hz, P=0.024. Mann-Whitney U-test.

  • Fig. 4 Left otoacoustic emission graphic of frequency and sound noise ratio changes of patient and control groups. Frequency of left otoacoustic emission: 1.0 Hz, P=0.005; 1.4 Hz, P=0.213; 2.0 Hz, P=0.357; 2.8 Hz, P=0.212; 4.0 Hz, P=0.076. Mann-Whitney U-test.


Reference

1. Wright V, Moll JM. Psoriatric arthritis. In : Wright V, Moll JM, editors. Seronegative polyarthritis. Amsterdam: North Holland Publishing Co.;1976. p. 169–235.
2. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008; 7. 35(7):1354–1358. PMID: 18464305.
3. Amherd-Hoekstra A, Naher H, Lorenz HM, Enk AH. Psoriatic arthritis: a review. J Dtsch Dermatol Ges. 2010; 5. 8(5):332–339. PMID: 20015187.
Article
4. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1979; Sep-Oct. 88(5 Pt 1):585–589. PMID: 496191.
Article
5. Halligan CS, Bauch CD, Brey RH, Achenbach SJ, Bamlet WR, McDonald TJ, et al. Hearing loss in rheumatoid arthritis. Laryngoscope. 2006; 11. 116(11):2044–2049. PMID: 17075400.
Article
6. Dagli M, Sivas Acar F, Karabulut H, Eryilmaz A, Erkol Inal E. Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int. 2007; 4. 27(6):511–516. PMID: 17094003.
Article
7. Dagli M, Eryilmaz A, Tanrikulu S, Aydin A, Gonul M, Gul U, et al. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behcet's disease. Auris Nasus Larynx. 2008; 9. 35(3):333–337. PMID: 17996415.
8. Hatzopoulos S, Amoroso C, Aimoni C, Lo Monaco A, Govoni M, Martini A. Hearing loss evaluation of Sjogren's syndrome using distortion product otoacoustic emissions. Acta Otolaryngol Suppl. 2002; (548):20–25. PMID: 12211351.
Article
9. Karatas E, Onat AM, Durucu C, Baglam T, Kanlikama M, Altunoren O, et al. Audiovestibular disturbance in patients with systemic lupus erythematosus. Otolaryngol Head Neck Surg. 2007; 1. 136(1):82–86. PMID: 17210339.
Article
10. Srikumar S, Deepak MK, Basu S, Kumar BN. Sensorineural hearing loss associated with psoriatic arthritis. J Laryngol Otol. 2004; 11. 118(11):909–911. PMID: 15638985.
Article
11. Giani T, Simonini G, Lunardi C, Puccetti A, De Martino M, Falcini F. Juvenile psoriatic arthritis and acquired sensorineural hearing loss in a teenager: is there an association? Clin Exp Rheumatol. 2006; May-Jun. 24(3):344–346. PMID: 16870107.
12. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006; 8. 54(8):2665–2673. PMID: 16871531.
Article
13. van de Kerkhof PC. The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol. 1997; 10. 137(4):661–662. PMID: 9390363.
14. American Speech-Language-Hearing Association. Guidelines for screening for hearing impairment and middle-ear disorders. Working Group on Acoustic Immittance Measurements and the Committee on Audiologic Evaluation. ASHA Suppl. 1990; 4. (2):17–24. PMID: 1970249.
15. Gladman DD. Current concepts in psoriatic arthritis. Curr Opin Rheumatol. 2002; 7. 14(4):361–366. PMID: 12118168.
Article
16. Harris JP. Immunology of the inner ear: evidence of local antibody production. Ann Otol Rhinol Laryngol. 1984; Mar-Apr. 93(2 Pt 1):157–162. PMID: 6712089.
Article
17. Mogi G, Kawauchi H, Suzuki M, Sato N. Inner ear immunology. Am J Otolaryngol. 1985; May-Jun. 6(3):142–147. PMID: 4014576.
18. Yoo TJ, Yazawa Y. Immunology of cochlear and vestibular disorders. In : Luxon LM, Furman JM, Martini A, Stephens D, editors. Textbook of audiological medicine: clinical aspects of hearing and balance. London: Taylor & Francis Group;2003. p. 61–88.
19. Kumar BN, Walsh RM, Wilson PS, Carlin WV. Sensorineural hearing loss and ulcerative colitis. J Laryngol Otol. 1997; 3. 111(3):277–278. PMID: 9156068.
Article
20. Garcia Berrocal JR, Ramirez-Camacho R, Vargas JA, Millan I. Does the serological testing really play a role in the diagnosis immune-mediated inner ear disease? Acta Otolaryngol. 2002; 4. 122(3):243–248. PMID: 12030569.
21. Bovo R, Aimoni C, Martini A. Immune-mediated inner ear disease. Acta Otolaryngol. 2006; 10. 126(10):1012–1021. PMID: 16923703.
Article
22. Lockshin MD. Sex differences in autoimmune disease. Lupus. 2006; 11. 15(11):753–756. PMID: 17153846.
Article
23. Karabulut H, Karadag AS, Dagli M, Acar B, Babademez MA, Sahin Y, et al. Investigation of hearing and outer hair cell function of cochlea in patients with psoriasis. Int Adv Otol. 2010; 1. 6(2):239–244.
24. Salvinelli F, D'Ascanio L, Casale M. Staging rheumatoid arthritis: what about otoacoustic emissions? Acta Otolaryngol. 2004; 9. 124(7):874–875. PMID: 15370576.
Article
25. Harris JP, Keithley EM, Gopen Q. Autoimmune ear disease and other autoimmune diseases with inner ear involvement. In : Snow JB, editor. Ballenger's manual of otorhinolaryngology head and neck surgery. Hamilton: BC Decker;2002. p. 396–407.
26. Bayindir T, Filiz A, Iraz M, Kaya S, Tan M, Kalcioglu MT. Evaluation of the protective effect of Beta glucan on amikacin ototoxicity using distortion product otoacoustic emission measurements in rats. Clin Exp Otorhinolaryngol. 2013; 3. 6(1):1–6. PMID: 23525870.
Article
27. Prieve BA, Fitzgerald TS. Otoacoustic emissions. In : Katz J, Burkard R, Medwetsky L, editors. Handbook of clinical audiology. 5th ed. Philadelphia: Lippincott Williams & Wilkins;2002. p. 440–466.
Full Text Links
  • CEO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr